Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
HK Stock MarketDetailed Quotes
06185 CANSINOBIO
- 33.950
- +3.550+11.68%
Market Closed Apr 30 16:08 CST
8.40BMarket Cap-35.18P/E (TTM)
34.750High30.700Low3.32MVolume30.700Open30.400Pre Close110.30MTurnover2.50%Turnover RatioLossP/E (Static)247.45MShares42.20052wk High1.58P/B4.50BFloat Cap16.34052wk Low--Dividend TTM132.67MShs Float449.063Historical High--Dividend LFY13.32%Amplitude14.800Historical Low33.270Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
About CANSINOBIO Company
The company was founded in 2009 in China with the mission of providing solutions for the prevention and treatment of infectious diseases worldwide, focusing on the R&D, production and commercialization of innovative, high-quality, and accessible human vaccines, and is an industry-leading high-tech biological products enterprise. Cansino Biotech's mission has always been to “provide the world with innovative, high-quality, and accessible vaccines” to achieve the corporate vision of “endless innovation, a world free of diseases”. The company is currently mainly engaged in vaccine research, development, production and commercialization. The main commercialized and ongoing products are meningococcal conjugate vaccine, pneumococcal conjugate vaccine, component 100 DPT vaccine, recombinant polio vaccine, etc. The main products are MCV4, MCV2, AD5-nCoV, inhaled AD5-nCoV and xBB.1.5 variant vaccines, AD5-eBoV, etc. Corporate honors: National High-tech Enterprise, Tianjin Key Laboratory for Respiratory Bacterial Recombination and Combined Vaccine Enterprises, Nankai University Talent Training Cooperation and Development Base, Tianjin Model Collective, and the company has won various honors such as Tianjin Manufacturing Individual Champion Enterprise, Tianjin Specialized and New Small and Medium Enterprises, and Tianjin Advanced Smart Factory.
Company Profile
Symbol06185
Company NameCANSINOBIO
ISINCNE100003F01
Listing DateMar 28, 2019
Issue Price22.00
Shares Offered57.25M share(s)
FoundedJan 13, 2009
Registered AddressChina
ChairmanXuefeng YU
Secretaryjinzhaomingjing cui
Audit InstitutionDeloitte Guan Huang Chen Fang Certified Public Accountants
Company CategoryOther
Registered Office401-420, 4th Floor, West District Biomedical Park, No. 185 South Street, West District, Tianjin Economic and Technological Development Zone
Head Office and Principal Place of BusinessRoom 1901, 19th floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong
Fiscal Year Ends12-31
Employees1105
MarketHong Kong motherboard
Phone022-58213766
Fax022-58213626
Emailir@cansinotech.com
BusinessLicense items: Class III medical device business; pharmaceutical production; pharmaceutical import and export; drug retail; pharmaceutical wholesale; import and export of goods; technology import and export. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments. Specific business projects are subject to documents or licenses approved by relevant departments) General projects: Class I medical device sales; Class II medical device sales; medical research and experimental development; technical services, technology development, technical consultation, technology exchange, technology transfer, and technology promotion. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with the law)
Company Executives
- Name
- Position
- Salary
- Xuefeng YU
- Chairman of the Board, CEOs, Executive Director, General Manager, Member of the Remuneration and Assessment Committee, Nomination Committee Members, Authorized Representative
- --
- Shou Bai CHAO
- Executive Director, Deputy General Manager, Chief Operating Officer
- --
- jing wang
- Executive Director, Deputy General Manager, Chief Commercial Officer
- --
- shuifa gui
- Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
- --
- jianzhong liu
- Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members
- --
- yaoliang zhang
- Independent Non-Executive Director, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
- --
- zhongqi shao
- Non-employee Representative Supervisor
- --
- zhi xiao
- Chairman of the Supervisory Board, Non-employee Representative Supervisor
- --
- chang sun
- Employee Representative Supervisor
- --
- jin cui
- Joint Company Secretary, Board Secretary
- --
- mingjing zhao
- Joint Company Secretary, Authorized Representative
- --
- tao zhu
- Chief Scientific Officer
- --
- Dongxu QIU
- Deputy General Manager, Senior Vice President
- --
- zhicheng li
- Non-executive Directors, Nomination Committee Members
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts